DHR · Danaher Corporation Common Stock
View on chartInsiders & Stakes
| Steven M. Rales Chairman | ▲ Buy | Grant | 3,605,808 Shares held | 8/4/2026 | View profile |
| Mitchell P. Rales Executive Chair of Board | ▲ Buy | Grant | 553,228 Shares held | 8/4/2026 | View profile |
| Alan G. Spoon Director | ▲ Buy | Grant | 124,774 Shares held | 5/15/2026 | View profile |
| Joakim Weidemanis Chief Executive Officer | ▼ Sell | Tax Withholding | 87,333 Shares held | 5/15/2024 | View profile |
| Christopher Paul Riley Executive Vice President | ▲ Buy | Grant | 61,472 Shares held | 8/4/2026 | View profile |
| William King Director | ▼ Sell | Tax Withholding | 48,190 Shares held | 5/15/2024 | View profile |
| Angela S. Lalor Director | ▼ Sell | Tax Withholding | 47,962 Shares held | 2/24/2022 | View profile |
| Elias A. Zerhouni Vice Chairman and President | ▼ Sell | Tax Withholding | 45,303 Shares held | 7/15/2026 | View profile |
| Jose-Carlos Gutierrez-Ramos SVP, Chief Science Officer | ▲ Buy | Grant | 32,495 Shares held | 8/4/2026 | View profile |
| Linda Filler Director | ▼ Sell | Tax Withholding | 26,829 Shares held | 7/15/2026 | View profile |
| Matthew McGrew EVP & Chief Financial Officer | ▲ Buy | Grant | 26,825 Shares held | 3/1/2026 | View profile |
| Jennifer Honeycutt President and CEO | ▼ Sell | Tax Withholding | 26,165 Shares held | 5/15/2023 | View profile |
| Gregory M. Milosevich Executive Vice President | ▲ Buy | Grant | 24,467 Shares held | 8/4/2026 | View profile |
| Sawyer Montgomery Julie A Executive Vice President | ▼ Sell | Tax Withholding | 22,221 Shares held | 3/1/2026 | View profile |
| Teri List Director | ▲ Buy | Grant | 21,470 Shares held | 5/15/2026 | View profile |
| John T. Schwieters Director | ▼ Sell | Tax Withholding | 19,815 Shares held | 7/15/2025 | View profile |
| LUTZ ROBERT S SVP-Chief Accounting Officer | ▼ Sell | Open Market | 16,155 Shares held | 8/13/2021 | View profile |
| Brian W. Ellis Director | ▲ Buy | Grant | 14,994 Shares held | 2/4/2026 | View profile |
| GRAY R BRADLEY SVP Strategic Development | ▲ Buy | Grant | 14,463 Shares held | 3/1/2026 | View profile |
| Walter G. Lohr Director | ▼ Sell | Open Market | 14,129 Shares held | 2/15/2024 | View profile |
| Raymond C. Stevens CHIEF EXECUTIVE OFFICER | ▲ Buy | Grant | 13,728 Shares held | 5/15/2026 | View profile |
| Jonathan Leiken EVP, CLO and Secretary | ▲ Buy | Grant | 12,546 Shares held | 3/1/2026 | View profile |
| Gugino Matthew E EVP & Chief Financial Officer | ▼ Sell | Tax Withholding | 11,401 Shares held | 3/1/2026 | View profile |
| Daniel Raskas Director | ▼ Sell | Tax Withholding | 10,524 Shares held | 2/3/2025 | View profile |
| Christopher Bouda VP, Chief Accounting Officer | ▼ Sell | Tax Withholding | 9,107 Shares held | 7/15/2026 | View profile |
| Georgeann Couchara SVP, Human Resources | ▼ Sell | Tax Withholding | 8,291 Shares held | 5/15/2026 | View profile |
| A. Shane Sanders Director | ▲ Buy | Grant | 5,914 Shares held | 5/15/2026 | View profile |
| Sabeti Pardis C Director | ▲ Buy | Grant | 5,283 Shares held | 5/15/2024 | View profile |
| Feroz Dewan Director | ▲ Buy | Grant | 4,686 Shares held | 5/15/2026 | View profile |
| Jessica L. Mega Director | ▲ Buy | Grant | 3,302 Shares held | 5/15/2025 | View profile |
| Charles W. Lamanna Director | ▲ Buy | Grant | 1,359 Shares held | 5/15/2026 | View profile |
| Blair Rainer President & CEO | ▼ Sell | Open Market | 0 Shares held | 8/21/2026 | View profile |
| DANAHER CORP /DE/ 10% Owner | ▼ Sell | Other | 0 Shares held | 9/30/2023 | View profile |
Transaction History
| Blair Rainer | ▼ Sell | Open Market | 39,193 | $8.6M | 8/21/2026 |
| Blair Rainer | ▼ Sell | Open Market | 7,755 | $1.7M | 8/21/2026 |
| Blair Rainer | ▼ Sell | Open Market | 11,307 | $2.5M | 8/21/2026 |
| Christopher Paul Riley | ▲ Buy | Grant | 41,072 | $0 | 8/4/2026 |
| Jose-Carlos Gutierrez-Ramos | ▲ Buy | Grant | 13,477 | $0 | 8/4/2026 |
| Gregory M. Milosevich | ▲ Buy | Grant | 15,402 | $0 | 8/4/2026 |
| Mitchell P. Rales | ▲ Buy | Grant | 500,000 | $0 | 8/4/2026 |
| Steven M. Rales | ▲ Buy | Grant | 500,000 | $0 | 8/4/2026 |
| Christopher Bouda | ▼ Sell | Tax Withholding | 60 | $12K | 7/15/2026 |
| Linda Filler | ▲ Buy | Option Exercise | 3,298 | $237K | 7/15/2026 |
| Linda Filler | ▼ Sell | Tax Withholding | 1,181 | $237K | 7/15/2026 |
| Elias A. Zerhouni | ▲ Buy | Option Exercise | 3,298 | $237K | 7/15/2026 |
| Elias A. Zerhouni | ▼ Sell | Tax Withholding | 1,181 | $237K | 7/15/2026 |
| Linda Filler | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| Georgeann Couchara | ▼ Sell | Tax Withholding | 281 | $45K | 5/15/2026 |
| Raymond C. Stevens | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| Alan G. Spoon | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| A. Shane Sanders | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| Teri List | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| Elias A. Zerhouni | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| Feroz Dewan | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| Charles W. Lamanna | ▲ Buy | Grant | 680 | $0 | 5/15/2026 |
| Alan G. Spoon | ▲ Buy | Option Exercise | 3,298 | $237K | 5/1/2026 |
| Alan G. Spoon | ▼ Sell | Open Market | 1,358 | $237K | 5/1/2026 |
| Jonathan Leiken | ▲ Buy | Grant | 2,374 | $0 | 3/1/2026 |
| Matthew McGrew | ▲ Buy | Grant | 5,935 | $0 | 3/1/2026 |
| Gregory M. Milosevich | ▲ Buy | Grant | 4,273 | $0 | 3/1/2026 |
| Gregory M. Milosevich | ▼ Sell | Tax Withholding | 118 | $25K | 3/1/2026 |
| Christopher Bouda | ▲ Buy | Grant | 1,247 | $0 | 3/1/2026 |
| Christopher Bouda | ▼ Sell | Tax Withholding | 170 | $36K | 3/1/2026 |
| Gugino Matthew E | ▼ Sell | Tax Withholding | 231 | $49K | 3/1/2026 |
| Jose-Carlos Gutierrez-Ramos | ▲ Buy | Grant | 6,647 | $0 | 3/1/2026 |
| Jose-Carlos Gutierrez-Ramos | ▼ Sell | Tax Withholding | 284 | $60K | 3/1/2026 |
| Christopher Paul Riley | ▲ Buy | Grant | 6,172 | $0 | 3/1/2026 |
| Christopher Paul Riley | ▼ Sell | Tax Withholding | 1,115 | $235K | 3/1/2026 |
| GRAY R BRADLEY | ▲ Buy | Grant | 2,849 | $0 | 3/1/2026 |
| Blair Rainer | ▲ Buy | Grant | 17,566 | $0 | 3/1/2026 |
| Gugino Matthew E | ▲ Buy | Grant | 3,988 | $0 | 3/1/2026 |
| Sawyer Montgomery Julie A | ▲ Buy | Grant | 6,172 | $0 | 3/1/2026 |
| Sawyer Montgomery Julie A | ▼ Sell | Tax Withholding | 1,080 | $227K | 3/1/2026 |
| Georgeann Couchara | ▲ Buy | Grant | 4,748 | $0 | 3/1/2026 |
| Georgeann Couchara | ▼ Sell | Tax Withholding | 113 | $24K | 3/1/2026 |
| Mitchell P. Rales | ▼ Sell | Gift | 71,648 | $0 | 2/27/2026 |
| Georgeann Couchara | ▼ Sell | Tax Withholding | 101 | $21K | 2/24/2026 |
| Jose-Carlos Gutierrez-Ramos | ▼ Sell | Tax Withholding | 344 | $72K | 2/24/2026 |
| Christopher Bouda | ▼ Sell | Tax Withholding | 235 | $49K | 2/24/2026 |
| Gregory M. Milosevich | ▼ Sell | Tax Withholding | 189 | $40K | 2/24/2026 |
| Sawyer Montgomery Julie A | ▼ Sell | Tax Withholding | 372 | $78K | 2/24/2026 |
| Christopher Paul Riley | ▼ Sell | Tax Withholding | 242 | $51K | 2/24/2026 |
| Gregory M. Milosevich | ▲ Buy | Option Exercise | 1,320 | $77K | 2/19/2026 |
| Gregory M. Milosevich | ▼ Sell | Open Market | 1,320 | $275K | 2/19/2026 |
| Brian W. Ellis | ▲ Buy | Grant | 1,695 | $0 | 2/4/2026 |
| Christopher Paul Riley | ▲ Buy | Grant | 1,046 | $0 | 2/4/2026 |
| Jose-Carlos Gutierrez-Ramos | ▲ Buy | Grant | 1,695 | $0 | 2/4/2026 |
| Georgeann Couchara | ▲ Buy | Grant | 1,413 | $0 | 2/4/2026 |
| Sawyer Montgomery Julie A | ▲ Buy | Grant | 848 | $0 | 2/4/2026 |
| Blair Rainer | ▲ Buy | Grant | 8,474 | $0 | 2/4/2026 |
| Matthew McGrew | ▲ Buy | Grant | 2,684 | $0 | 2/4/2026 |
| Gregory M. Milosevich | ▲ Buy | Grant | 679 | $0 | 2/4/2026 |
| Jose-Carlos Gutierrez-Ramos | ▼ Sell | Tax Withholding | 852 | $190K | 2/2/2026 |
| Brian W. Ellis | ▼ Sell | Tax Withholding | 1,254 | $280K | 2/2/2026 |
| Matthew McGrew | ▼ Sell | Tax Withholding | 1,856 | $415K | 2/2/2026 |
| Christopher Paul Riley | ▼ Sell | Tax Withholding | 640 | $143K | 2/2/2026 |
| Blair Rainer | ▼ Sell | Tax Withholding | 7,750 | $1.7M | 2/2/2026 |
| Mitchell P. Rales | ▼ Sell | Open Market | 35,899 | $8.3M | 11/25/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 4,726 | $1.1M | 11/25/2025 |
| Mitchell P. Rales | ▼ Sell | Gift | 22,029 | $0 | 11/25/2025 |
| Teri List | ▲ Buy | Option Exercise | 3,298 | $237K | 11/18/2025 |
| Teri List | ▼ Sell | Open Market | 3,298 | $747K | 11/18/2025 |
| Gregory M. Milosevich | ▼ Sell | Tax Withholding | 35 | $8K | 11/15/2025 |
| Sawyer Montgomery Julie A | ▼ Sell | Tax Withholding | 265 | $59K | 11/15/2025 |
| GRAY R BRADLEY | ▼ Sell | Tax Withholding | 1,402 | $310K | 11/15/2025 |
| Jonathan Leiken | ▲ Buy | Grant | 10,172 | $0 | 11/15/2025 |
| Brian W. Ellis | ▲ Buy | Option Exercise | 7,109 | $417K | 11/12/2025 |
| Brian W. Ellis | ▼ Sell | Open Market | 7,109 | $1.6M | 11/12/2025 |
| Brian W. Ellis | ▲ Buy | Option Exercise | 14,667 | $859K | 11/12/2025 |
| Brian W. Ellis | ▼ Sell | Open Market | 14,667 | $3.2M | 11/12/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 25,855 | $5.6M | 11/12/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 254,553 | $55.6M | 11/12/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 133,233 | $29.2M | 11/12/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 23,359 | $5.1M | 11/12/2025 |
| Matthew McGrew | ▲ Buy | Option Exercise | 16,172 | $1.0M | 11/11/2025 |
| Matthew McGrew | ▼ Sell | Open Market | 16,172 | $3.5M | 11/11/2025 |
| Georgeann Couchara | ▼ Sell | Open Market | 998 | $210K | 11/10/2025 |
| Georgeann Couchara | ▲ Buy | Option Exercise | 4,176 | $368K | 11/10/2025 |
| Georgeann Couchara | ▼ Sell | Open Market | 4,176 | $879K | 11/10/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 223,449 | $48.3M | 10/31/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 308,423 | $66.5M | 10/31/2025 |
| Mitchell P. Rales | ▼ Sell | Open Market | 68,128 | $14.8M | 10/31/2025 |
| Teri List | ▼ Sell | Open Market | 2,778 | $586K | 8/22/2025 |
| Elias A. Zerhouni | ▲ Buy | Option Exercise | 3,928 | $233K | 7/15/2025 |
| Elias A. Zerhouni | ▼ Sell | Tax Withholding | 1,209 | $233K | 7/15/2025 |
| John T. Schwieters | ▲ Buy | Option Exercise | 3,928 | $233K | 7/15/2025 |
| John T. Schwieters | ▼ Sell | Tax Withholding | 1,209 | $233K | 7/15/2025 |
| Christopher Bouda | ▼ Sell | Tax Withholding | 61 | $12K | 7/15/2025 |
| Teri List | ▲ Buy | Option Exercise | 3,928 | $233K | 7/2/2025 |
| Teri List | ▼ Sell | Tax Withholding | 1,150 | $233K | 7/2/2025 |
| Blair Rainer | ▼ Sell | Gift | 27,490 | $0 | 5/15/2025 |
| Charles W. Lamanna | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Linda Filler | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Jessica L. Mega | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Georgeann Couchara | ▼ Sell | Tax Withholding | 281 | $54K | 5/15/2025 |
| A. Shane Sanders | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Elias A. Zerhouni | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Feroz Dewan | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Raymond C. Stevens | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Alan G. Spoon | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| John T. Schwieters | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Teri List | ▲ Buy | Grant | 577 | $0 | 5/15/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 166,225 | $32.3M | 5/12/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 355,668 | $69.3M | 5/12/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 109,801 | $21.5M | 5/12/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 189,314 | $37.3M | 5/12/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 58,313 | $11.5M | 5/12/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 164,412 | $32.7M | 5/12/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 158,951 | $31.7M | 5/12/2025 |
| Steven M. Rales | ▼ Sell | Open Market | 47,316 | $9.5M | 5/12/2025 |
| Christopher Paul Riley | ▲ Buy | Option Exercise | 7,801 | $597K | 4/30/2025 |
| Christopher Paul Riley | ▼ Sell | Open Market | 7,801 | $1.5M | 4/30/2025 |
| Christopher Paul Riley | ▼ Sell | Open Market | 8,004 | $1.6M | 4/30/2025 |
| Charles W. Lamanna | ▲ Buy | Grant | 102 | $0 | 3/1/2025 |
| Sawyer Montgomery Julie A | ▲ Buy | Grant | 12,034 | $0 | 3/1/2025 |
| Jose-Carlos Gutierrez-Ramos | ▼ Sell | Tax Withholding | 216 | $45K | 3/1/2025 |
| Georgeann Couchara | ▼ Sell | Tax Withholding | 111 | $23K | 3/1/2025 |
| Christopher Bouda | ▲ Buy | Grant | 1,264 | $0 | 3/1/2025 |
| Christopher Bouda | ▼ Sell | Tax Withholding | 74 | $15K | 3/1/2025 |
| Christopher Paul Riley | ▲ Buy | Grant | 12,034 | $0 | 3/1/2025 |
| Jose-Carlos Gutierrez-Ramos | ▼ Sell | Tax Withholding | 586 | $124K | 2/24/2025 |
| Sawyer Montgomery Julie A | ▼ Sell | Tax Withholding | 618 | $130K | 2/24/2025 |
| Christopher Bouda | ▼ Sell | Tax Withholding | 285 | $60K | 2/24/2025 |
| Christopher Paul Riley | ▼ Sell | Tax Withholding | 348 | $73K | 2/24/2025 |
| Georgeann Couchara | ▼ Sell | Tax Withholding | 197 | $42K | 2/24/2025 |
| Alan G. Spoon | ▲ Buy | Option Exercise | 3,928 | $233K | 2/7/2025 |
| Alan G. Spoon | ▼ Sell | Open Market | 550 | $114K | 2/7/2025 |
| Daniel Raskas | ▼ Sell | Tax Withholding | 4,701 | $1.0M | 2/3/2025 |
| Blair Rainer | ▼ Sell | Tax Withholding | 20,030 | $4.3M | 2/3/2025 |
| Matthew McGrew | ▼ Sell | Tax Withholding | 9,345 | $2.0M | 2/3/2025 |
| Brian W. Ellis | ▼ Sell | Tax Withholding | 5,677 | $1.2M | 2/3/2025 |
| Christopher Paul Riley | ▼ Sell | Tax Withholding | 3,074 | $659K | 2/3/2025 |
| Brian W. Ellis | ▲ Buy | Option Exercise | 5,700 | $334K | 1/30/2025 |
| Brian W. Ellis | ▼ Sell | Open Market | 5,700 | $1.3M | 1/30/2025 |
| Daniel Raskas | ▼ Sell | Open Market | 26,318 | $6.2M | 11/26/2024 |
| Daniel Raskas | ▲ Buy | Option Exercise | 26,318 | $1.5M | 11/26/2024 |
| Daniel Raskas | ▼ Sell | Open Market | 8,370 | $2.0M | 11/25/2024 |
| Christopher Bouda | ▼ Sell | Other | 75 | $18K | 11/21/2024 |
| Mitchell P. Rales | ▼ Sell | Gift | 616 | $0 | 11/21/2024 |
| Matthew McGrew | ▼ Sell | Other | 1,318 | $310K | 11/21/2024 |
| Sawyer Montgomery Julie A | ▼ Sell | Tax Withholding | 265 | $61K | 11/15/2024 |
| GRAY R BRADLEY | ▲ Buy | Grant | 13,016 | $0 | 11/15/2024 |
| Georgeann Couchara | ▼ Sell | Open Market | 952 | $255K | 8/26/2024 |
| Blair Rainer | ▼ Sell | Gift | 30,765 | $0 | 8/1/2024 |
| Linda Filler | ▲ Buy | Option Exercise | 3,928 | $233K | 8/1/2024 |
| Linda Filler | ▼ Sell | Open Market | 3,928 | $1.1M | 8/1/2024 |
| Matthew McGrew | ▲ Buy | Option Exercise | 16,172 | $1.0M | 8/1/2024 |
| Matthew McGrew | ▼ Sell | Open Market | 16,172 | $4.5M | 8/1/2024 |
| Blair Rainer | ▼ Sell | Open Market | 9,007 | $2.5M | 7/31/2024 |
| Brian W. Ellis | ▼ Sell | Open Market | 9,600 | $2.6M | 7/25/2024 |
| Daniel Raskas | ▼ Sell | Open Market | 14,507 | $3.9M | 7/25/2024 |
| Elias A. Zerhouni | ▲ Buy | Option Exercise | 3,289 | $173K | 7/15/2024 |
| Sawyer Montgomery Julie A | ▼ Sell | Tax Withholding | 105 | $26K | 7/15/2024 |
| Christopher Bouda | ▼ Sell | Tax Withholding | 61 | $15K | 7/15/2024 |
| John T. Schwieters | ▲ Buy | Option Exercise | 3,289 | $173K | 7/15/2024 |
| John T. Schwieters | ▼ Sell | Tax Withholding | 703 | $173K | 7/15/2024 |
| Elias A. Zerhouni | ▼ Sell | Tax Withholding | 703 | $173K | 7/15/2024 |
| Blair Rainer | ▼ Sell | Open Market | 9,005 | $2.4M | 5/16/2024 |
| William King | ▼ Sell | Tax Withholding | 7,018 | $1.8M | 5/15/2024 |
| William King | ▲ Buy | Option Exercise | 12,623 | $636K | 5/15/2024 |
| Alan G. Spoon | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Georgeann Couchara | ▼ Sell | Tax Withholding | 281 | $74K | 5/15/2024 |
| Feroz Dewan | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Sabeti Pardis C | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Elias A. Zerhouni | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Linda Filler | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Joakim Weidemanis | ▼ Sell | Tax Withholding | 3,079 | $811K | 5/15/2024 |
| A. Shane Sanders | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Teri List | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Raymond C. Stevens | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Jessica L. Mega | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Christopher Paul Riley | ▼ Sell | Tax Withholding | 320 | $84K | 5/15/2024 |
| John T. Schwieters | ▲ Buy | Grant | 390 | $0 | 5/15/2024 |
| Blair Rainer | ▲ Buy | Option Exercise | 5,926 | $372K | 5/14/2024 |
| Blair Rainer | ▲ Buy | Option Exercise | 13,159 | $771K | 5/14/2024 |
| Blair Rainer | ▼ Sell | Open Market | 19,085 | $4.9M | 5/14/2024 |
| Matthew McGrew | ▼ Sell | Open Market | 21,203 | $5.4M | 5/10/2024 |
| Matthew McGrew | ▲ Buy | Option Exercise | 9,243 | $541K | 5/10/2024 |
| Matthew McGrew | ▼ Sell | Open Market | 9,243 | $2.3M | 5/10/2024 |
| Matthew McGrew | ▲ Buy | Option Exercise | 15,931 | $1.0M | 5/10/2024 |
| Matthew McGrew | ▼ Sell | Open Market | 15,931 | $4.0M | 5/10/2024 |
| Alan G. Spoon | ▼ Sell | Open Market | 708 | $172K | 5/2/2024 |
| Alan G. Spoon | ▲ Buy | Option Exercise | 3,289 | $173K | 5/2/2024 |
| Joakim Weidemanis | ▲ Buy | Option Exercise | 22,433 | $1.3M | 4/25/2024 |
| Joakim Weidemanis | ▼ Sell | Open Market | 22,433 | $5.6M | 4/25/2024 |
| Brian W. Ellis | ▼ Sell | Open Market | 4,000 | $1.0M | 4/24/2024 |
| Blair Rainer | ▼ Sell | Open Market | 9,005 | $2.3M | 4/24/2024 |
| Blair Rainer | ▲ Buy | Option Exercise | 26,318 | $1.5M | 4/24/2024 |
| Blair Rainer | ▼ Sell | Open Market | 38,170 | $9.5M | 4/24/2024 |
| Blair Rainer | ▲ Buy | Option Exercise | 11,852 | $745K | 4/24/2024 |
| Christopher Bouda | ▲ Buy | Grant | 978 | $0 | 3/1/2024 |
| Joakim Weidemanis | ▲ Buy | Grant | 978 | $0 | 3/1/2024 |
| Georgeann Couchara | ▲ Buy | Grant | 1,466 | $0 | 3/1/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Danaher Expands AI Integration in Scientific Research
Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.
Danaher Expands AI Integration in Scientific Research. Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.